Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Name Common Trade Name(s) Classificationsort icon Date Marketed in Canada (yyyy/mm/dd)
Drotrecogin alfa Xigris Antithrombotic profibrinolytic anti-inflammatory enzyme 2011/10/25
Caplacizumab Cablivi Antithrombotic agent 2020/09/04
Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide Genvoya Antiretroviral agents 2016/02/03
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate Stribild Antiretroviral agent 2012/12/20
Emtricitabine + tenofovir Descovy Antiretroviral agent 2016/06/03
Cabotegravir Vocabria Antiretroviral agent 2020/03/19
Cabotegravir + rilpivirine Cabenuva Antiretroviral agent 2020/03/19
Aripiprazole Abilify Antipsychotic agent 2009/07/03
Paliperidone palmitate Invega Sustenna Antipsychotic agent 2010/07/28
Paliperidone Invega Antipsychotic agent 2007/10/02
Brexpiprazole Rexulti Antipsychotic agent 2017/04/20
Prasugrel Effient Antiplatelet agent 2020/01/31
Aluminum chloride hexahydrate Hydrosal gel Antiperspirant
Rotigotine Neupro Antiparkinsonian agent / Dopamine agonist 2013/09/12
Brolucizumab Beovu Antineovascularisation agent 2020/05/15
Pomalidomide Pomalyst Antineoplastic agent; immunmodulator 2014/02/24
Daratumumab Darzalex SC Antineoplastic agent, monoclonal antibody 2020/08/12
Isatuximab Sarclisa Antineoplastic agent, monoclonal antibody 2020/07/03
Enasidenib IDHIFA Antineoplastic agent / IDH2 Inhibitor 2019/02/27
Degarelix Firmagon Antineoplastic agent 2009/11
Lapatinib ditosylate Tykerb Antineoplastic agent 2009/05
Azacitidine Vidaza Antineoplastic agent 2009/12/07
Everolimus Afinitor Antineoplastic agent 2010/02/12
Trabectedin Yondelis Antineoplastic agent 2010/08/04
Lenalidomide Revlimid Antineoplastic agent
Pazopanib Votrient Antineoplastic agent 2011/08/25
Ipilimumab Yervoy Antineoplastic agent 2012/03
Cabazitaxel Jevtana Antineoplastic agent 2011/06
Eribulin Halaven Antineoplastic agent 2012/03/10
Ruxolitinib Jakavi Antineoplastic agent 2012/07/18
Ofatumumab Arzerra Antineoplastic agent 2012/03/09
Vemurafenib Zelboraf Antineoplastic agent 2012/02
Pertuzumab Perjeta Antineoplastic agent 2013/04/23
Regorafenib Stivarga Antineoplastic agent 2013/03/11
Trastuzumab emtansine Kadcyla Antineoplastic agent 2013/09/27
Bendamustine Treanda Antineoplastic agent 2012/09/12
Syndicate content